Cargando…
Anticoagulation management : a guidebook for pharmacists /
In addition to acting as a training guide for pharmacists, pharmacy residents and pharmacy students who seek to practice in areas associated with patients on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find use...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham :
Adis,
2015.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Anticoagulation Management; Preface; Abbreviations; Contents; Contributors; Part 1: Medication Management; Chapter 1: Inpatient Warfarin Management; 1.1 Introduction; 1.2 Case Examples; 1.2.1 Case 1; 1.2.2 Case 2; 1.2.3 Case 3; 1.3 Role of the Pharmacist in Inpatient Vitamin K Antagonist Management; 1.4 Warfarin Management Guidelines and Protocols; 1.4.1 Warfarin Initiation; 1.4.2 Warfarin Maintenance; 1.5 Monitoring and Interpreting Laboratory Values; 1.5.1 International Normalized Ratio (INR); 1.5.2 Complete Blood Count (CBC); 1.5.3 Pregnancy Testing; 1.5.4 Genetic Testing.
- 1.6 Assessment of Drug Interactions1.7 Patient Education; 1.8 Documentation; 1.9 Conclusions; References; Chapter 2: Ambulatory Warfarin Management; 2.1 Introduction; 2.2 Case Examples; 2.2.1 Case 1; 2.2.2 Case 2; 2.2.3 Case 3; 2.3 Role of the Pharmacist in Ambulatory Warfarin Management; 2.4 Warfarin Management Guidelines and Protocols; 2.4.1 Indication for Warfarin Therapy; 2.4.2 Patient Assessment; 2.4.3 Initial Warfarin Dosing; 2.4.4 Maintenance Warfarin Dosing; 2.5 Monitoring Laboratory Values and Patient Assessment; 2.5.1 Monitoring Laboratory Values; 2.5.2 Patient Assessment.
- 2.6 Assessment of Drug Interactions2.7 Patient Education and Compliance; 2.7.1 Patient Education; 2.7.2 Patient Compliance; 2.8 Documentation; 2.9 Conclusion; References; Chapter 3: Unfractionated Heparin and Low Molecular Weight Heparin; 3.1 Introduction; 3.2 Case Examples; 3.2.1 Case 1; 3.2.2 Case 2; 3.2.3 Case 3; 3.3 The Role of the Pharmacist; 3.3.1 UFH Management; 3.3.2 LMWH Management; 3.4 Management Guidelines and Protocols; 3.4.1 UFH Management Guidelines and Protocols; 3.4.2 LMWH Management; 3.5 Monitoring and Interpreting Laboratory Values; 3.5.1 Maintenance Monitoring of UFH.
- 3.5.2 Maintenance Monitoring of LMWH3.6 Documentation; 3.7 Patient Education; 3.8 Future Roles; 3.9 Conclusion; References; Chapter 4: Direct Oral Anticoagulants; 4.1 Introduction; 4.2 Case Examples; 4.2.1 Case 1; 4.2.2 Case 2; 4.3 Pharmacist Role in DOAC Management; 4.4 DOAC Drug Selection and Management; 4.4.1 Anticoagulant Selection [5-17]; Prosthetic Heart Valves; Geriatric Patients; Renal Impairment; Dialysis; Hepatic Impairment; Pregnancy/Lactation; Pediatrics; Contraindications; 4.4.2 DOAC Selection; 4.4.3 DOAC Dosing; 4.5 Monitoring and Interpreting Laboratory Values.
- 4.5.1 Labs to Determine Coagulation Status [20, 21]4.5.2 Labs to Monitor for Appropriate DOAC Dosing [8-17, 19]; 4.6 Drug Interactions [22]; 4.6.1 Pharmacokinetic Drug Interactions; P-gp Inhibitors and Inducers; CYP 3A4 Inhibitors and Inducers; 4.6.2 Pharmacodynamic Drug Interactions; Medications that Inhibit Platelet (PLT) Aggregation; 4.7 Transitioning Between Anticoagulants [23-25, 27]; 4.7.1 Periprocedural Planning; 4.7.2 Reversal Strategies [28]; 4.8 Patient Education [19]; 4.9 Future Roles; 4.9.1 Anticoagulation Clinics; 4.9.2 Reimbursement; 4.10 Conclusion; References.